Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A02775 | 34248137 | Med Sci Monit | Editorial: International Consensus Recommendations to Replace the Terminology of Non-Alcoholic Fatty Liver Disease (NAFLD) with Metabolic-Associated Fatty Liver Disease (MAFLD). | 2021 | Details |
| A02776 | 34246549 | Hepatobiliary Pancreat Dis Int | The pathologic relevance of metabolic criteria in patients with biopsy-proven nonalcoholic fatty liver disease and metabolic dysfunction associated fatty liver disease: A multicenter cross-sectional study in China. | 2021 | Details |
| A02777 | 34245170 | J Food Biochem | Ziziphus spina-christi (L.) fortified with Camellia sinensis mediates apoptosis, Notch-1 signaling, and mitigates obesity-induced non-alcoholic fatty liver. | 2021 | Details |
| A02778 | 34244048 | Nutr Metab Cardiovasc Dis | Early identification of metabolic syndrome risk: A review of reviews and proposal for defining pre-metabolic syndrome status. | 2021 | Details |
| A02779 | 34243681 | Pharm Biol | Esculin protects against methionine choline-deficient diet-induced non-alcoholic steatohepatitis by regulating the Sirt1/NF-κB p65 pathway. | 2021 | Details |
| A02780 | 34243194 | Semin Liver Dis | Risks and Rewards of Bariatric Surgery in Advanced Chronic Liver Diseases. | 2021 | Details |
| A02781 | 34243193 | Semin Liver Dis | Management of Obesity and Nonalcoholic Fatty Liver Disease: A Literature Review. | 2021 | Details |
| A02782 | 34242868 | Comput Biol Med | Application of computer tongue image analysis technology in the diagnosis of NAFLD. | 2021 | Details |
| A02783 | 34242696 | J Hepatol | The multifaceted role of cathepsins in liver disease. | 2021 | Details |
| A02784 | 34242656 | Am J Pathol | Methionine- and Choline-Deficient Diet-Induced Nonalcoholic Steatohepatitis Is Associated with Increased Intestinal Inflammation. | 2021 | Details |
| A02785 | 34242466 | Liver Int | Outcomes and potential surrogate markers for future clinical trials of non-alcoholic steatohepatitis cirrhosis. | 2021 | Details |
| A02786 | 34241659 | Arch Toxicol | Sex-dependent dynamics of metabolism in primary mouse hepatocytes. | 2021 | Details |
| A02787 | 34240649 | Int J Immunopathol Pharmacol | Allopurinol ameliorates liver injury in type 1 diabetic rats through activating Nrf2. | 2022 | Details |
| A02788 | 34239714 | Oman Med J | Effect of SGLT-2 Inhibitors on Non-alcoholic Fatty Liver Disease among Patients with Type 2 Diabetes Mellitus: Systematic Review with Meta-analysis and Trial Sequential Analysis of Randomized Clinical Trials. | 2021 | Details |
| A02789 | 34239698 | World J Hepatol | Glutathione-S-transferases genes-promising predictors of hepatic dysfunction. | 2021 | Details |
| A02790 | 34239622 | Dis Markers | Jiangzhi Ligan Decoction Inhibits GSDMD-Mediated Canonical/Noncanonical Pyroptosis Pathways and Alleviates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A02791 | 34239263 | World J Gastroenterol | Non-cirrhotic hepatocellular carcinoma in chronic viral hepatitis: Current insights and advancements. | 2021 | Details |
| A02792 | 34239138 | Nat Med | Efruxifermin in non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a trial. | 2021 | Details |
| A02793 | 34238770 | Gut Liver | Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease. | 2022 | Details |
| A02794 | 34238176 | Curr Mol Pharmacol | The Protective Role of Etoricoxib Against Diethylnitrosamine/2-acetylaminofluorene- Induced Hepatocarcinogenesis in Wistar Rats: The Impact of NF-κB/COX-2/PGE2 Signaling. | 2022 | Details |
| A02795 | 34237252 | Cell Metab | Liver-fibrosis-activated transcriptional networks govern hepatocyte reprogramming and intra-hepatic communication. | 2021 | Details |
| A02796 | 34236487 | Semin Immunopathol | Role of bile acids in inflammatory liver diseases. | 2021 | Details |
| A02797 | 34236046 | JCI Insight | Zebrafish mutants provide insights into Apolipoprotein B functions during embryonic development and pathological conditions. | 2021 | Details |
| A02798 | 34235516 | Food Funct | The interaction between gut microbiota and flavonoid extract from Smilax glabra Roxb. and its potent alleviation of fatty liver. | 2021 | Details |
| A02799 | 34235481 | Curr Res Struct Biol | A two-stage computational approach to predict novel ligands for a chemosensory receptor. | 2020 | Details |
| A02800 | 34234682 | Front Pharmacol | The Anti-Obesity Effect of Traditional Chinese Medicine on Lipid Metabolism. | 2021 | Details |
| A02801 | 34234538 | Int J Gen Med | Correlation Between 25 Hydroxyvitamin D Levels and Nonalcoholic Fatty Liver Disease in Chinese Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study. | 2021 | Details |
| A02802 | 34234521 | Int J Gen Med | Application of a Novel Prediction Model for Predicting 2-Year Risk of Non-Alcoholic Fatty Liver Disease in the Non-Obese Population with Normal Blood Lipid Levels: A Large Prospective Cohort Study from China. | 2021 | Details |
| A02803 | 34234491 | Diabetes Metab Syndr Obes | Evaluation Through the Optical Coherence Tomography Analysis of the Influence of Non-Alcoholic Fatty Liver Disease on the Gingival Inflammation in Periodontal Patients. | 2021 | Details |
| A02804 | 34234263 | Sci Rep | Copy number variation in the CES1 gene and the risk of non-alcoholic fatty liver in a Chinese Han population. | 2021 | Details |
| A02805 | 34234198 | Sci Rep | Utility of Fibroscan XL to assess the severity of non-alcoholic fatty liver disease in patients undergoing bariatric surgery. | 2021 | Details |
| A02806 | 34234100 | Cell Death Discov | Exosomes secreted by palmitic acid-treated hepatocytes promote LX-2 cell activation by transferring miRNA-107. | 2021 | Details |
| A02807 | 34233850 | Hepatobiliary Pancreat Dis Int | Key factors and potential drug combinations of nonalcoholic steatohepatitis: Bioinformatic analysis and experimental validation-based study. | 2021 | Details |
| A02808 | 34233762 | BMC Nutr | Associations of maternal diet and nutritional status with offspring hepatic steatosis in the Avon longitudinal study of parents and children. | 2021 | Details |
| A02809 | 34233370 | Semin Liver Dis | Insights into Nonalcoholic Fatty-Liver Disease Heterogeneity. | 2021 | Details |
| A02810 | 34233158 | Mol Cell | SREBP-1c impairs ULK1 sulfhydration-mediated autophagic flux to promote hepatic steatosis in high-fat-diet-fed mice. | 2021 | Details |
| A02814 | 34233024 | Hepatology | A Mammalian Target of Rapamycin-Perilipin 3 (mTORC1-Plin3) Pathway is essential to Activate Lipophagy and Protects Against Hepatosteatosis. | 2021 | Details |
| A02815 | 34231659 | Arq Gastroenterol | PERFORMACE OF TRIGLYCERIDE-GLUCOSE INDEX ON DIAGNOSIS AND STAGING OF NAFLD IN OBESE PATIENTS. | 2021 | Details |
| A02816 | 34231477 | Turk J Gastroenterol | Feasibility of Fibroscan in Assessment of Hepatic Steatosis and Fibrosis in Obese Patients: Report From a General Internal Medicine Clinic. | 2021 | Details |
| A02817 | 34231476 | Turk J Gastroenterol | Systolic Blood Pressure Mediates Body Mass Index and Non-alcoholic Fatty Liver Disease: A Population-Based Study. | 2021 | Details |
| A02818 | 34231324 | Physiol Rep | Crosstalk between beta-adrenergic and insulin signaling mediates mechanistic target of rapamycin hyperactivation in liver of high-fat diet-fed male mice. | 2021 | Details |
| A02819 | 34231239 | Hepatology | Fatty Acid Synthase-Suppressor Screening Identifies Sorting Nexin 8 as a Therapeutic Target for NAFLD. | 2021 | Details |
| A02820 | 34230921 | MedComm (2020) | Sex differences in clinical characteristics and risk factors for disease severity of hospitalized patients with COVID-19. | 2021 | Details |
| A02823 | 34229251 | Biomed Pharmacother | Bicyclol ameliorates nonalcoholic fatty liver disease in mice via inhibiting MAPKs and NF-κB signaling pathways. | 2021 | Details |
| A02824 | 34229038 | Clin Gastroenterol Hepatol | A Global Survey of Physicians Knowledge About Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A02826 | 34228977 | Biochimie | Citrin deficiency: Does the reactivation of liver aralar-1 come into play and promote HCC development? | 2021 | Details |
| A02827 | 34227216 | Diabetes Obes Metab | Impact of SGLT2 inhibitors in comparison with DPP4 inhibitors on ascites and death in veterans with cirrhosis on metformin. | 2021 | Details |
| A02828 | 34227068 | Eur Rev Med Pharmacol Sci | Liver changes in Wilson's disease: the full spectrum. A report of 127 biopsies from 43 patients. | 2021 | Details |
| A02829 | 34226721 | Nat Methods | SpaceM reveals metabolic states of single cells. | 2021 | Details |
| A02830 | 34226630 | Sci Rep | The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases. | 2021 | Details |
| A02831 | 34226120 | Nutr Metab Cardiovasc Dis | Insulin resistance and NAFLD may influence memory performance in obese patients with prediabetes or newly-diagnosed type 2 diabetes. | 2021 | Details |
| A02832 | 34225483 | mBio | Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice. | 2021 | Details |
| A02833 | 34225440 | Zhonghua Gan Zang Bing Za Zhi | [Research progress of omics biomarkers for nonalcoholic fatty liver disease]. | 2021 | Details |
| A02834 | 34225438 | Zhonghua Gan Zang Bing Za Zhi | [Mechanism of T lymphocyte subsets in the malignant transformation of non-alcoholic fatty liver disease]. | 2021 | Details |
| A02835 | 34225424 | Zhonghua Gan Zang Bing Za Zhi | [Role of gut-liver-immune axis in the pathogenesis of nonalcoholic steatohepatitis]. | 2021 | Details |
| A02836 | 34224858 | Pharmacol Res | Mastiha has efficacy in immune-mediated inflammatory diseases through a microRNA-155 Th17 dependent action. | 2021 | Details |
| A02837 | 34224779 | J Hepatol | Non-alcoholic fatty liver disease in children and young adults is associated with increased long-term mortality. | 2021 | Details |
| A02838 | 34224699 | Eur J Pharmacol | Dapagliflozin attenuates steatosis in livers of high-fat diet-induced mice and oleic acid-treated L02 cells via regulating AMPK/mTOR pathway. | 2021 | Details |
| A02839 | 34224565 | J Nutr | Brown Rice Inhibits Development of Nonalcoholic Fatty Liver Disease in Obese Zucker (fa/fa) Rats by Increasing Lipid Oxidation Via Activation of Retinoic Acid Synthesis. | 2021 | Details |
| A02840 | 34222711 | Curr Opin Endocr Metab Res | Pediatric nonalcoholic fatty liver disease and the microbiome: Mechanisms contributing to pathogenesis and progression. | 2021 | Details |
| A02841 | 34222135 | Can J Gastroenterol Hepatol | Regulation of Mitochondrial Function by Natural Products for the Treatment of Metabolic Associated Fatty Liver Disease. | 2021 | Details |
| A02842 | 34221929 | J Clin Transl Hepatol | Nonalcoholic Fatty Liver Disease after Liver Transplant. | 2021 | Details |
| A02843 | 34221923 | J Clin Transl Hepatol | Icaritin Attenuates Lipid Accumulation by Increasing Energy Expenditure and Autophagy Regulated by Phosphorylating AMPK. | 2021 | Details |
| A02844 | 34221537 | Liver Res | Vitamins and non-alcoholic fatty liver disease: A Molecular Insight⋆. | 2021 | Details |
| A02845 | 34221404 | SAGE Open Med Case Rep | Ibuprofen-associated minimal change disease and acute interstitial nephritis with possibly linked membranous glomerulonephritis. | 2021 | Details |
| A02846 | 34221262 | Gastroenterol Hepatol Bed Bench | Is melatonin associated with pro-inflammatory cytokine activity and liver fibrosis in non-alcoholic fatty liver disease (NAFLD) patients? | 2021 | Details |
| A02847 | 34221261 | Gastroenterol Hepatol Bed Bench | The association between food insulin index and odds of non-alcoholic fatty liver disease (NAFLD) in adults: a case-control study. | 2021 | Details |
| A02848 | 34220701 | Front Endocrinol (Lausanne) | Effect of SGLT2 Inhibitors on Type 2 Diabetes Mellitus With Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials. | 2021 | Details |
| A02849 | 34219362 | Liver Int | The relationship between frailty and cirrhosis etiology: From the Functional Assessment in Liver Transplantation (FrAILT) Study. | 2021 | Details |
| A02850 | 34219361 | Liver Int | PPAR-γ-induced changes in visceral fat and adiponectin levels are associated with improvement of steatohepatitis in patients with NASH. | 2021 | Details |
| A02851 | 34219352 | Liver Int | Incidence of liver-related morbidity and mortality in a population cohort of non-alcoholic fatty liver disease. | 2021 | Details |
| A02852 | 34219227 | Eur J Clin Invest | The role of RIPK3 in liver mitochondria bioenergetics and function. | 2021 | Details |
| A02853 | 34219018 | J Diabetes Complications | The prevalence of gestational diabetes mellitus in women diagnosed with non-alcoholic fatty liver disease during pregnancy: A systematic review and meta-analysis. | 2021 | Details |
| A02854 | 34218773 | Curr Pharm Des | Vanillic Acid and Non-Alcoholic Fatty Liver Disease: A Focus on AMPK in Adipose and Liver Tissues. | 2021 | Details |
| A02855 | 34214678 | Clin Gastroenterol Hepatol | Physical Activity Is Associated With Nonalcoholic Fatty Liver Disease and Significant Fibrosis Measured by FibroScan. | 2021 | Details |
| A02856 | 34214585 | Eur J Pharmacol | The leukotriene receptor antagonist montelukast in the treatment of non-alcoholic steatohepatitis: A proof-of-concept, randomized, double-blind, placebo-controlled trial. | 2021 | Details |
| A02857 | 34214406 | Expert Opin Investig Drugs | Anti-diabetic drugs and NASH: from current options to promising perspectives. | 2021 | Details |
| A02858 | 34214382 | J Basic Clin Physiol Pharmacol | The effect of various high-fat diet on liver histology in the development of NAFLD models in mice. | 2021 | Details |
| A02859 | 34214346 | J Basic Clin Physiol Pharmacol | The effects of quercetin on the expression of SREBP-1c mRNA in high-fat diet-induced NAFLD in mice. | 2021 | Details |
| A02860 | 34213784 | Phytother Res | Corosolic acid ameliorates non-alcoholic steatohepatitis induced by high-fat diet and carbon tetrachloride by regulating TGF-β1/Smad2, NF-κB, and AMPK signaling pathways. | 2021 | Details |
| A02861 | 34213749 | Indian J Gastroenterol | Comparison of clinical and metabolic profiles of lean versus non-lean nonalcoholic fatty liver disease. | 2021 | Details |
| A02862 | 34213039 | J Clin Lab Anal | Risk of severe illness of COVID-19 patients with NAFLD and increased NAFLD fibrosis scores. | 2021 | Details |
| A02863 | 34212895 | Am J Gastroenterol | Chemopreventive Effect of Statin on Hepatocellular Carcinoma in Patients With Nonalcoholic Steatohepatitis Cirrhosis. | 2021 | Details |
| A02864 | 34212294 | Clin Exp Med | An exploratory analysis of the competing effects of alcohol use and advanced hepatic fibrosis on serum HDL. | 2021 | Details |
| A02865 | 34212214 | Inflamm Res | Mechanistic and physiological approaches of fecal microbiota transplantation in the management of NAFLD. | 2021 | Details |
| A02866 | 34211980 | Front Cell Dev Biol | Corrigendum: Exploring the Causality Between Hypothyroidism and Non-alcoholic Fatty Liver: A Mendelian Randomization Study. | 2021 | Details |
| A02867 | 34211743 | Curr Health Sci J | Assessment of Left Ventricular Diastolic Function in Young Adults with Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A02868 | 34211711 | SAGE Open Med | Frequency and risk factors of non-alcoholic fatty liver disease in Helicobacter pylori-infected dyspeptic patients: A cross-sectional study. | 2021 | Details |
| A02869 | 34211614 | Dis Markers | Hepatic Steatosis Index and Chronic Kidney Disease among Middle-Aged Individuals: A Large-Scale Study in Japan. | 2021 | Details |
| A02870 | 34211180 | Nat Metab | Intestinal MYC modulates obesity-related metabolic dysfunction. | 2021 | Details |
| A02871 | 34211157 | Nat Rev Gastroenterol Hepatol | New insights into IL-6 family cytokines in metabolism, hepatology and gastroenterology. | 2021 | Details |
| A02872 | 34211098 | Commun Biol | Deletion of the diabetes candidate gene Slc16a13 in mice attenuates diet-induced ectopic lipid accumulation and insulin resistance. | 2021 | Details |
| A02873 | 34210457 | Rev Gastroenterol Mex (Engl Ed) | Dietary and sociodemographic factors associated with nonalcoholic fatty liver in obese pediatric patients. | 2021 | Details |
| A02874 | 34209858 | J Clin Med | Systematic Review with Meta-Analyses: Diagnostic Accuracy of FibroMeter Tests in Patients with Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A02875 | 34209831 | J Clin Med | TSH Levels as an Independent Risk Factor for NAFLD and Liver Fibrosis in the General Population. | 2021 | Details |
| A02876 | 34209386 | Biomedicines | Role of Leptin in Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A02877 | 34208839 | J Pers Med | Is HSD17B13 Genetic Variant a Protector for Liver Dysfunction? Future Perspective as a Potential Therapeutic Target. | 2021 | Details |
| A02878 | 34208774 | Int J Mol Sci | Atorvastatin Modulates Bile Acid Homeostasis in Mice with Diet-Induced Nonalcoholic Steatohepatitis. | 2021 | Details |
| A02879 | 34208211 | Nutrients | Effect of Microalgae and Macroalgae Extracts on Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A02880 | 34207587 | Diagnostics (Basel) | Association of Skeletal Muscle and Adipose Tissue Distribution with Histologic Severity of Non-Alcoholic Fatty Liver. | 2021 | Details |